Advanced search
1 file | 3.59 MB Add to list

High-coverage immunopeptidomics using timsTOF mass spectrometers with thunder-DDA-PASEF boosted by MS2Rescore

Author
Organization
Abstract
Major histocompatibility complex (MHC, or human leukocyte antigen, HLA) peptide ligands can be exploited to develop immunotherapies targeting immunogenic disease-specific immunopeptides, such as virus- or cancer mutation-derived peptides. Liquid chromatography coupled with mass spectrometry (LC-MS)-based immunopeptidomics is the gold standard for identifying MHC ligands. We previously optimized a workflow enabling the identification of more than 10,000 MHC class I ligands per cell line. This process comprises three major steps: (I) a high-recovery immunopeptidome enrichment, (II) an optimized MS acquisition in the timsTOF Pro called Thunder-Data-Dependent Acquisition with Parallel Accumulation-SErial Fragmentation (Thunder-DDA-PASEF), and (III) peptide identification using PEAKS XPro boosted by MS2Rescore data-driven rescoring. Here, we describe our workflow for deep-coverage immunopeptidomics step-by-step, from sample preparation to data analysis and validation.
Keywords
immunopeptidomics, human leucocyte antigen, major histocompatibility complex, sample preparation, immunoprecipitation, mass spectrometry, rescoring

Downloads

  • (...).pdf
    • full text (Accepted manuscript)
    • |
    • UGent only (changes to open access on 2027-10-16)
    • |
    • PDF
    • |
    • 3.59 MB

Citation

Please use this url to cite or link to this publication:

MLA
Gomez-Zepeda, David, et al. “High-Coverage Immunopeptidomics Using TimsTOF Mass Spectrometers with Thunder-DDA-PASEF Boosted by MS2Rescore.” Immunoproteomics : Methods and Protocols, edited by Kelly M. Fulton and Susan M. Twine, 3rd ed., vol. 2980, Humana, 2025, pp. 115–55, doi:10.1007/978-1-0716-4832-2_5.
APA
Gomez-Zepeda, D., Beyrle, J., Preikschat, A., Declercq, A., Chen, Y., Gabriels, R., … Tenzer, S. (2025). High-coverage immunopeptidomics using timsTOF mass spectrometers with thunder-DDA-PASEF boosted by MS2Rescore. In K. M. Fulton & S. M. Twine (Eds.), Immunoproteomics : methods and protocols (3rd ed., Vol. 2980, pp. 115–155). https://doi.org/10.1007/978-1-0716-4832-2_5
Chicago author-date
Gomez-Zepeda, David, Julian Beyrle, Annica Preikschat, Arthur Declercq, Yannic Chen, Ralf Gabriels, Lennart Martens, Ute Distler, and Stefan Tenzer. 2025. “High-Coverage Immunopeptidomics Using TimsTOF Mass Spectrometers with Thunder-DDA-PASEF Boosted by MS2Rescore.” In Immunoproteomics : Methods and Protocols, edited by Kelly M. Fulton and Susan M. Twine, 3rd ed., 2980:115–55. New York: Humana. https://doi.org/10.1007/978-1-0716-4832-2_5.
Chicago author-date (all authors)
Gomez-Zepeda, David, Julian Beyrle, Annica Preikschat, Arthur Declercq, Yannic Chen, Ralf Gabriels, Lennart Martens, Ute Distler, and Stefan Tenzer. 2025. “High-Coverage Immunopeptidomics Using TimsTOF Mass Spectrometers with Thunder-DDA-PASEF Boosted by MS2Rescore.” In Immunoproteomics : Methods and Protocols, ed by. Kelly M. Fulton and Susan M. Twine, 2980:115–155. 3rd ed. New York: Humana. doi:10.1007/978-1-0716-4832-2_5.
Vancouver
1.
Gomez-Zepeda D, Beyrle J, Preikschat A, Declercq A, Chen Y, Gabriels R, et al. High-coverage immunopeptidomics using timsTOF mass spectrometers with thunder-DDA-PASEF boosted by MS2Rescore. In: Fulton KM, Twine SM, editors. Immunoproteomics : methods and protocols. 3rd ed. New York: Humana; 2025. p. 115–55.
IEEE
[1]
D. Gomez-Zepeda et al., “High-coverage immunopeptidomics using timsTOF mass spectrometers with thunder-DDA-PASEF boosted by MS2Rescore,” in Immunoproteomics : methods and protocols, 3rd ed., vol. 2980, K. M. Fulton and S. M. Twine, Eds. New York: Humana, 2025, pp. 115–155.
@incollection{01KAGDKRKTV1N0FWDFCNNX9M6P,
  abstract     = {{Major histocompatibility complex (MHC, or human leukocyte antigen, HLA) peptide ligands can be exploited to develop immunotherapies targeting immunogenic disease-specific immunopeptides, such as virus- or cancer mutation-derived peptides. Liquid chromatography coupled with mass spectrometry (LC-MS)-based immunopeptidomics is the gold standard for identifying MHC ligands. We previously optimized a workflow enabling the identification of more than 10,000 MHC class I ligands per cell line. This process comprises three major steps: (I) a high-recovery immunopeptidome enrichment, (II) an optimized MS acquisition in the timsTOF Pro called Thunder-Data-Dependent Acquisition with Parallel Accumulation-SErial Fragmentation (Thunder-DDA-PASEF), and (III) peptide identification using PEAKS XPro boosted by MS2Rescore data-driven rescoring. Here, we describe our workflow for deep-coverage immunopeptidomics step-by-step, from sample preparation to data analysis and validation.}},
  author       = {{Gomez-Zepeda, David and Beyrle, Julian and Preikschat, Annica and Declercq, Arthur and Chen, Yannic and Gabriels, Ralf and Martens, Lennart and Distler, Ute and Tenzer, Stefan}},
  booktitle    = {{Immunoproteomics : methods and protocols}},
  editor       = {{Fulton, Kelly M. and Twine, Susan M.}},
  isbn         = {{9781071648315}},
  issn         = {{1064-3745}},
  keywords     = {{immunopeptidomics,human leucocyte antigen,major histocompatibility complex,sample preparation,immunoprecipitation,mass spectrometry,rescoring}},
  language     = {{eng}},
  pages        = {{115--155}},
  publisher    = {{Humana}},
  series       = {{Methods in molecular biology (MIMB)}},
  title        = {{High-coverage immunopeptidomics using timsTOF mass spectrometers with thunder-DDA-PASEF boosted by MS2Rescore}},
  url          = {{http://doi.org/10.1007/978-1-0716-4832-2_5}},
  volume       = {{2980}},
  year         = {{2025}},
}

Altmetric
View in Altmetric